Picture of Everest Medicines logo

1952 Everest Medicines Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareHighly SpeculativeMid CapMomentum Trap

Annual cashflow statement for Everest Medicines, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-5,658-1,009-247-844-1,041
Depreciation
Amortisation
Non-Cash Items5,088184-95166.5354
Unusual Items
Other Non-Cash Items
Changes in Working Capital77.963.2-0.323-68-126
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-472-730-1,156-769-680
Capital Expenditures-520-976-433-266-204
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0-5951,0181,179
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-520-976-1,028752974
Financing Cash Flow Items0-7.95-19.7
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities5,638-76.5-25.310.137.8
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash4,375-1,841-2,14932.3361